BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201107
DTEND;VALUE=DATE:20201110
DTSTAMP:20260415T200906
CREATED:20200916T094658Z
LAST-MODIFIED:20200916T101354Z
UID:24386-1604707200-1604966399@www.braincouncil.eu
SUMMARY:The ESO-WSO Virtual Conference
DESCRIPTION:The ESO-WSO Virtual Conference will meet the needs of the stroke community and offer major clinical trials\, state-of-the-art presentations by renowned clinicians and researchers\, and updates on the latest guidelines. \nThe Virtual Conference will take place on 7-9 November 2020. Virtual sessions will allow live interaction and will be available on-demand in the weeks following the Conference. \nThe Conference is organized by the European Stroke Organisation (ESO)\, a pan-European society of stroke researchers and physicians\, national and regional stroke societies and lay organisations and the World Stroke Organization (WSO) which aims to reduce the global burden of stroke through prevention\, treatment and long term care. WSO is approved by the World Health Organization (WHO) as a non-governmental organization for official relations.
URL:https://www.braincouncil.eu/event/the-eso-wso-virtual-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20201124T100000
DTEND;TZID=UTC:20201124T114500
DTSTAMP:20260415T200906
CREATED:20201113T150052Z
LAST-MODIFIED:20201113T150052Z
UID:26019-1606212000-1606218300@www.braincouncil.eu
SUMMARY:Virtual workshop on good practices for the off-label use of medicines in Sweden and Norway
DESCRIPTION:The use of medicines off-label plays an important role in various areas of medicine as it allows patients to be treated in cases where an authorised drug is not available for a specific therapeutic indication\, population or method of administration. Despite its importance\, off-label prescription lacks a clear and uniform approach at European level. As elsewhere in Europe\, physicians in the Nordics prescribe medicines off-label to treat conditions where there are no approved products on the market. However there is a lack of an aligned strategy among agencies and decision makers when it comes to dealing this matter\, with different health care regions in the countries taking different approaches. \nTo maintain the highest levels of patient safety and minimise any adverse events\, while not limiting the access to medications off-label when there is an unmet medical need\, a number of organisations put forward the Declaration on Good Off-Label Use Practice (so called GOLUP) as a basis for discussion across Europe. Following a launch event in Brussels\, workshops have been held in Rome and Madrid to present the GOLUP and discuss it with local stakeholders and decisionmakers. \nSPEAKERS: \n• Maria Prigorowsky\, Head of Public Affairs\, Hjärnfonden\, The Swedish Brain Foundation \n• Lise Johnson\, Chair of the board\, MSforbundet\, The Norwegian MS Association \n• Frédéric Destrebecq\, Executive Director\, The European Brain Council \n• Synnöve Lindemalm\, Karolinska University Hospital and representative of ePed (an evidence-based database for the Swedish pediatric population) \n• Elisabeth Gulowsen Celius\, University of Oslo\, Department of Neurology \n• Thony Björk\, Medicines expert\, SPF Seniorerna\, The Swedish Association for Senior Citizens \n• Dag Larsson\, Senior policy expert\, Läkemedelsindustriföreningen\, Trade association for the research based pharmaceutical industry in Sweden \n• Line Walen\, Senior Policy Advisor\, Legemiddelindustrien\, Trade association for the pharmaceutical industry in Norway \n• Jenni Nordborg\, National Coordinator and Director of the Office for Life Sciences\, Government Offices of Sweden \nSpeakers will provide their remarks in English\, followed by a Q&A session where the audience will have the option to intervene in Swedish/Norwegian. \n  \nWe look forward to welcoming you online: please register your attendance.
URL:https://www.braincouncil.eu/event/virtual-workshop-on-good-practices-for-the-off-label-use-of-medicines-in-sweden-and-norway/
END:VEVENT
END:VCALENDAR